SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-032148
Filing Date
2020-03-12
Accepted
2020-03-12 07:11:57
Documents
3
Period of Report
2020-03-12
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2012017d3_8k.htm 8-K 19296
2 EXHIBIT 99.1 tm2012017d3_ex99-1.htm EX-99.1 92514
3 GRAPHIC tm2012017d3_ex99-1img001.jpg GRAPHIC 23998
  Complete submission text file 0001104659-20-032148.txt   146331
Mailing Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063
Business Address 200 CARDINAL WAY, 2ND FLOOR REDWOOD CITY CA 94063 650-486-1416
Menlo Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38356 | Film No.: 20707142
SIC: 2834 Pharmaceutical Preparations